Zurich-Schlieren
Switzerland
2
2009-01-29
2
2018-03-06
These are the the leading inventors for applications assigned to ESBATech AG:
ESBATech AG based in Zurich-Schlieren, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Sequence based engineering and optimization of single chain antibodies
#2 | 2008-05-22 ✅ Patent 7,902,340 granted on 2011-03-08Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK
241545 ⎘